This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alastair M. Buchan, MD, FRCPC

Arch Neurol. 1992;49(4):420-421.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

L-glutamate, a major excitatory amino acid neurotransmitter, rather surprisingly appears to act as an endogenous neurotoxin.¹ The "excitotoxic hypothesis" postulates that abnormal levels of excitatory amino acids occur and, by excessive synaptic stimulation, drive neurons to a premature death.² Cell culture observation has implicated calcium flux through the N-methyl-D-aspartate (NMDA) linked ionophore as the critical metabolic event³ leading to the conjecture that NMDA antagonists will prevent neuronal injury.⁴ Most of the evidence that supports this belief is derived from hypoxic-ischemia—related experimentation, but attempts have been made to generalize the theory and practice of NMDA antagonism to other neurologic disease processes and their treatment.5 Models of diseases such as Parkinson's disease, Alzheimer's disease, and motor neuron disease are compromised by our current lack of understanding of the molecular basis of their etiology and their link to pathologically elevated glutamate levels is at best . . . [Full Text PDF of this Article]

Author Affiliations
From the Division of Neurology and Neuroscience, Ottawa (Ontario) Civic Hospital.

Footnotes
Accepted for publication September 5, 1991.

Reprint requests to Division of Neurology and Neuroscience, Ottawa Civic Hospital, 1053 Carling Ave, Ottawa, Ontario, Canada KIY 4E9 (Dr Buchan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?